Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_3
1
25%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)

Trials by Status

withdrawn125%
recruiting125%
completed250%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

CPAP for the Treatment of Supine Hypertension

NCT05489575
withdrawnnot_applicable

Reproductive Aging and Obstructive Sleep Apnea

NCT01850992
completedphase_3

Apnea Positive Pressure Long-Term Efficacy Study

NCT00051363
completedphase_4

Antihypertensive Effect of Continuous Positive Airway Pressure in Resistant Hypertensive Patients With Sleep Apnea

NCT00929175

Clinical Trials (4)

Showing 4 of 4 trials
NCT05489575Not Applicable

CPAP for the Treatment of Supine Hypertension

Recruiting
NCT01850992Not Applicable

Reproductive Aging and Obstructive Sleep Apnea

Withdrawn
NCT00051363Phase 3

Apnea Positive Pressure Long-Term Efficacy Study

Completed
NCT00929175Phase 4

Antihypertensive Effect of Continuous Positive Airway Pressure in Resistant Hypertensive Patients With Sleep Apnea

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4